Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

LOUISA T HO

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1932122322
CMS profile
1215179
Location
EVANSTON, IL

General Payments · PY2019–2025

$7,659.38

  • Reported across 142 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$468.00

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $468.00 15

By paying entity

PY2025 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $396.01 4
PY2020 $141.03 3
PY2021 $338.64 12
PY2022 $957.58 34
PY2023 $821.77 32
PY2024 $4,536.35 42
PY2025 $468.00 15

Payment records · PY2025 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $26.51 01/14/2025 Food and Beverage Undisputed 06/30/2026 1202943106 CMS
Amgen Inc. $18.00 07/22/2025 Food and Beverage Undisputed 06/30/2026 1228416896 CMS
AstraZeneca Pharmaceuticals LP $28.58 03/19/2025 Food and Beverage Undisputed 06/30/2026 1206502248 CMS
Aurinia Pharma U.S., Inc. $20.65 01/07/2025 Food and Beverage Undisputed 06/30/2026 1249403360 CMS
Bayer Healthcare Pharmaceuticals Inc. $29.66 05/13/2025 Food and Beverage Undisputed 06/30/2026 1225577112 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.57 06/17/2025 Food and Beverage Undisputed 06/30/2026 1222942266 CMS
Calliditas Therapeutics US Inc. $25.40 04/29/2025 Food and Beverage Undisputed 06/30/2026 1234997900 CMS
Mallinckrodt Hospital Products Inc. $24.99 02/18/2025 Food and Beverage Undisputed 06/30/2026 1211970566 CMS
Mallinckrodt Hospital Products Inc. $25.00 11/11/2025 Food and Beverage Undisputed 06/30/2026 1211970568 CMS
Novartis Pharmaceuticals Corporation $28.08 07/08/2025 Food and Beverage Undisputed 06/30/2026 1200348777 CMS
Novartis Pharmaceuticals Corporation $120.34 11/19/2025 Food and Beverage Undisputed 06/30/2026 1200286300 CMS
Otsuka America Pharmaceutical, Inc. $24.37 01/22/2025 Food and Beverage Undisputed 06/30/2026 1227350347 CMS
Otsuka America Pharmaceutical, Inc. $26.45 07/30/2025 Food and Beverage Undisputed 06/30/2026 1227350351 CMS
Otsuka America Pharmaceutical, Inc. $19.69 12/17/2025 Food and Beverage Undisputed 06/30/2026 1227350355 CMS
Travere Therapeutics, Inc. $23.71 02/17/2025 Food and Beverage Undisputed 06/30/2026 1244419862 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.